Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction

American Journal Geriatric Pharmacotherapy

Volumn 6, Issue 1, 2008, Pages 33-36

  Howard Thompson, Amanda ^a,b   Hurdle, April C ^a,b   Arnold, Lori B ^a,b   Finch, Christopher K ^a,b   Sands, Christopher ^b   Self, Timothy H ^a,b  

^a METHODIST UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

interaction; intracerebral hemorrhage; metronidazole; warfarin

Indexed keywords

CITALOPRAM; CLONIDINE; FRESH FROZEN PLASMA; LEVOFLOXACIN; LEVOTHYROXINE; METOPROLOL; METRONIDAZOLE; MONTELUKAST; POTASSIUM CHLORIDE; TEGASEROD; VITAMIN K GROUP; WARFARIN;

ABDOMINAL HYSTERECTOMY; AGED; ALLERGIC RHINITIS; ANAMNESIS; ANXIETY DISORDER; ARTICLE; BEDTIME DOSAGE; BRAIN HEMORRHAGE; CASE REPORT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INTERNATIONAL NORMALIZED RATIO; INTERPERSONAL COMMUNICATION; LENGTH OF STAY; LUNG EMBOLISM; MEDICAL DECISION MAKING; NEPHROLITHIASIS; NEPHROLITHOTOMY; OCCIPITAL LOBE; PEPTIC ULCER; POLYPHARMACY; PRIORITY JOURNAL; PROBABILITY; RATING SCALE; TRANSIENT ISCHEMIC ATTACK; UPPER RESPIRATORY TRACT INFECTION;

AGED; ANTI-INFECTIVE AGENTS; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; DRUG INTERACTIONS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; METRONIDAZOLE; WARFARIN;

EID: 44249120340     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2008.03.003     Document Type: Article

References (20)

1. Ansell J., Hirsh J., Poller L., et al. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. [published correction appears in Chest. 2005; 127:415-416]. Chest 126 Suppl 3 (2004) 204S-233S
2. Franco V., Polanczyk C., Clausell N., and Rohde L. Role of dietary vitamin K intake in chronic oral anticoagulation: Prospective evidence from observational and randomized protocols. Am J Med 116 (2004) 651-656
3. Nilsson O., Lindgren A., Ståhl N., et al. Incidence of intracerebral and subarachnoid hemorrhage in southern Sweden. J Neurol Neurosurg Psychiatry 69 (2000) 601-607
4. Sudlow C., Warlow C., and for the International Stroke Incidence Collaboration. Comparable studies of the incidence of stroke and its pathological types: Results from an international collaboration. Stroke 28 (1997) 491-499
5. Kolominsky-Rabas P., Sarti C., Heuschmann P., et al. A prospective community-based study of stroke in Germany-the Erlangen Stroke Project (ESPro): Incidence and case fatality at 1, 3, and 12 months. Stroke 29 (1998) 2501-2506
6. Steiner T., Rosand J., and Diringer M. Intracerebral hemorrhage associated with oral anticoagulant therapy: Current practices and unresolved questions. Stroke 37 (2006) 256-262
7. Panneerselvam S., Baglin C., Lefort W., and Baglin T. Analysis of risk factors for over-anticoagulation in patients receiving long-term warfarin. Br J Haematol 103 (1998) 422-424
8. Jönsson A., Spigset O., Jacobsson I., and Hägg S. Cerebral hemorrhage induced by warfarin-the influence of drug-drug interactions. Pharmacoepidemiol Drug Saf 16 (2007) 309-315
9. O'Reilly R. The stereoselective interaction of warfarin and metronidazole in man. N Engl J Med 295 (1976) 354-357
10. Kazmier F. A significant interaction between metronidazole and warfarin. Mayo Clin Proc 51 (1976) 782-784
11. Dean R., and Talbert R. Bleeding associated with concurrent warfarin and metronidazole therapy. Drug Intell Clin Pharm 14 (1980) 864-866
12. Feldstein A., Smith D., Perrin N., et al. Reducing warfarin medication interactions: An interrupted time series evaluation. Arch Intern Med 166 (2006) 1009-1015
13. Toon S., Hopkins K., Garstang F., et al. Enoxacin-warfarin interaction: Pharmacokinetic and stereochemical aspects. Clin Pharmacol Ther 42 (1987) 33-41
14. Jolson H., Tanner L., Green L., et al. Adverse reaction reporting of interaction between warfarin and fluoroquinolones. Arch Intern Med 151 (1991) 1003-1004
15. Mathews S., Cole J., and Ryono R. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin. Pharmacotherapy 26 (2006) 1446-1452
16. Liao S., Palmer M., Fowler C., and Nayak R. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers. J Clin Pharmacol 36 (1996) 1072-1077
17. Yamreudeewong W., Lower D., Kilpatrick D., et al. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy. Pharmacotherapy 23 (2003) 333-338
18. Stroud L., Mamdami M., Kopp A., and Bell C. The safety of levofloxacin in elderly patients on warfarin. Am J Med 118 (2005) 1417
19. Naranjo C., Busto U., Sellers E., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
20. Hylek E. Oral anticoagulants. Pharmacologic issues for use in the elderly. Clin Geriatr Med 17 (2001) 1-13